report difficulties walking for a prolonged period of time. This study compares gait automaticity between women with CFS and nondisabled controls. The "stops walking with eyes closed with secondary cognitive task" test is based on the classic "stops walking while talking" test but compares walking with eyes closed while performing a secondary cognitive task in a female CFS population (n = 34) and in female nondisabled controls (n = 38). When initiating gate, 23.5% of patients with CFS looked toward the ground compared with only 2.6% of nondisabled controls. After 7 m, subjects were asked to close their eyes, and after another 7 m, they were asked, "How much is 100 minus 7?" Of the patients with CFS, 55.9% stopped walking compared with 5.3% of nondisabled controls. Less automated walking was observed in patients with CFS than in nondisabled controls (p < 0.001). The test-retest reliability is moderate for global stopping. This simple test observed reduced gait automaticity in patients with CFS for the first time. Dual tasking could be helpful to address the functional limitations found in this particular study.
INTRODUCTION
Chronic fatigue syndrome (CFS) is defined by the U.S. Centers for Disease Control and Prevention (CDC) as a condition characterized by self-reported, unexplained, persistent, or relapsing fatigue of at least 6 mo duration and the concurrent occurrence of multiple nonspecific symptoms, including sore throat, muscle and joint pain, headache, tender cervical or axillary lymph nodes, unrefreshing sleep, and postexertional malaise [1] . Complaints related to vision or vision-related tasks are often mentioned by patients with CFS [2] , and these patients typically report difficulties when standing or walking for a prolonged time [3] [4] [5] .
In a previous study using the timed loaded standing (TLS) test, female patients with CFS showed lower combined trunk and arm endurance than female nondisabled controls, women living in nonindustrialized countries with no diagnosis of CFS, and even older female osteoporotic patients [6] [7] . These findings might indicate patients with CFS are restricted in their ability to hold themselves upright against gravity.
The results from the TLS study in patients with CFS could be understood in parallel with poor working posture [8] . A relation has been shown between poor working posture and musculoskeletal disorders, stress, and discomfort [9] [10] [11] [12] . When working positions are not optimal, visual requirements have a greater influence on working posture than manual or bodily requirements [13] [14] [15] [16] [17] . The role of vision in controlling the direction and speed of gait is important, especially in complex and/or dark environments [18] .
The combined actions of walking and talking have been studied in nondisabled populations [19] [20] [21] and are affected by age. In the elderly, the "stops walking while talking" (SWWT) test has been found to be a good predictor of falls among frail, institutionalized elderly patients [22] [23] [24] . No information on initiating or stopping walking in patients with CFS was found in the literature. Most patients with CFS do not reach the daily recommended 10,000 steps [25] . Patients with CFS walk slower but also at a higher cost at matched velocity than nondisabled controls [26] .
It is not common practice to check for visual impairment in patients with CFS. However, patients with CFS show impairments in visual accommodation, are more sensitive to light than nondisabled controls [27] , and often report floaters as well as tear-related problems [28] . Research findings point to reduced visual capabilities (including reduced car driving capacity) [27] , slower tracking ability for moving objects, and worse visual attention [2, [29] [30] in patients with CFS.
Along with vision, cognitive performance is reduced in patients with CFS [31] [32] . When two concurrent tasks ask for more capacity than available, one of the tasks will be impaired or even stopped [33] . Nondisabled people are able to talk while walking or to walk with their eyes closed. However, as soon as automaticity is lost, the compensatory costs increase [34] [35] . Combining walking, talking, and paying specific visual attention to the surroundings can be difficult in patients with CFS [36] . To date, studies examining dual tasking (DT) in patients with CFS are unavailable. This also accounts for studies examining DT in relation to vision and walking in patients with CFS.
In order to compare and evaluate walking with eyes closed and performing a secondary cognitive task in a CFS population and in nondisabled controls, our group developed a new test entitled "stops walking with eyes closed with secondary cognitive task" (SWECCT), based on the SWWT test by Lundin-Olsson et al. [37] but adapted to the CFS population.
The SWWT test is a relatively simple physical test that challenges parallel motor and cognitive tasks; it has been found to be a good predictor of falls among frail, institutionalized elderly patients [37] . The SWWT test shows good specificity (95%) and acceptable positive predictive values (83%) along with negative predictive values (76%) with moderate sensitivity (48%) in the prediction of falls [38] [39] [40] [41] .
For the reasons outlined previously, the present study has three aims: (1) examine whether gait automaticity is different between patients with CFS and nondisabled controls, (2) examine the test-retest reliability of the SWECCT test for assessing gait automaticity in patients with CFS, and (3) examine whether impairment in gait automaticity is associated with combined trunk and arm endurance in patients with CFS.
First, we hypothesized that patients with CFS would show reduced gait automaticity compared with nondisabled controls. Second, we hypothesized that the SWECCT test would generate reliable data for assessing gait automaticity in patients with CFS. Third, we hypothesized that gait automaticity would be associated with combined trunk and arm endurance in patients with CFS.
METHODS

Study Participants
In total, 72 study participants were enrolled and completed the study. The CFS population (n = 34) were Belgian, Caucasian, Dutch-speaking, nonpregnant women (20-56 yr old; mean: 41 yr) who fulfilled the 1994 CDC diagnostic criteria [1] . Patients were evaluated and recruited by one physician (G.M.), who specializes in internal medicine and has extensive experience in diagnosing patients with CFS, at the outpatient clinic of general internal medicine at the Antwerp University Hospital (Antwerp, Belgium). All patients were carefully screened for other possible medical causes, signs, and symptoms, as is required for the diagnosis of CFS [42] . This implies standard blood testing and endocrinological, cardiac, pulmonary, and neurological screens as well as psychiatric screening.
The nondisabled female controls (n = 38) consisted of nurses and physicians recruited from the participating hospital (31-48 yr old; mean: 40 yr). Study participants were not allowed to report sick leave during the last 24 mo, were pain free, and were without any (chronic) disease at the time of study participation.
Study Design
The study was designed as a cross-sectional and casecontrolled comparison. The SWECCT test of patients with CFS and nondisabled controls was performed at the outpatient clinic of the general internal medicine department at the Antwerp University Hospital.
The study protocol was approved by the Ethics Committee of the Antwerp University Hospital. Study recruitment was performed by distribution of oral and written information at the outpatient clinic. Written informed consent was obtained from all participants. After collecting information on personal characteristics, the DT test was completed. In order to prevent bias due to pooling of sex data, only females were allowed to participate [7] .
Procedures
Stops Walking With Eyes Closed With Secondary Cognitive Task
We developed a low-tech, clinically applicable test entitled the SWECCT. The test is based on the classic SWWT test by Lundin-Olsson et al. first published in 1997 [37] . The SWWT test can be described as follows: patients walked with the eyes open, and when the examiner started a conversation, the patient either stopped when answering or went on walking.
Because our experience was that patients with CFS had difficulties positioning themselves in space when lacking visual data, we adapted the SWWT test to the SWECCT test, which consists of three phases: (1) initiation of gait with eyes open, (2) sustaining gait or stopping after closing the eyes, and (3) sustaining or stopping gait with eyes still closed when answering a simple cognitive question, "How much is 100 minus 7?" Subjects were placed along a quiet hospital corridor and asked to look in front of them. They were instructed to walk through the corridor at a normal pace as long as they could and informed that thereafter, at two consecutive times, another task would be given. We repeated that they had to continue walking as long as they could, adding that they would be safe because we would walk near them. During instructions, we stood 2 m in front of the subjects, a bit to the side, and checked whether their eyes were still aimed at the corridor's end [43] . We followed the subjects without any other intervention, except for instructing the two additional tasks and ensuring their safety.
The SWECCT test uses the following procedure (Figure 1) . At point A, we asked the subject to initiate walking. After 7 m (point B), we asked the subject to close her eyes, and after another 7 m (point C), we asked "How much is 100 minus 7?"
This made it possible to not only observe but also to quantify the combined functioning of balance, gait, vision, strength, and coordination with eyes closed and during performance of a simple cognitive task.
• At point A: Did subjects focus their eyes toward their feet or the ground when initiating gait? A score of 0 was given if no deterioration could be observed. A Scheme of "stops walking with eyes closed with secondary cognitive task" test. Point A: Starting position, subject standing with eyes aimed at end of corridor. Point B: After 7 m, ask subject to close eyes while walking. Point C: After another 7 m, ask subject to continue walking with eyes closed and ask "How much is 100 minus 7?" score of 1 was given if eyes were aimed at the ground when initiating gait.
• At point B: Did closing the eyes deteriorate gait? Did it make them stop walking? In order to register the observations in real time, the following codes were used at points B and C. If no deterioration could be observed, the score was 0; for slight deterioration (slowing down or extending the arms to keep balance), the score was 1. A score of 2 was given if subjects lost direction or changed their pace dramatically. If subjects opened their eyes, stopped, or had to be stopped for safety, a score of 3 was given.
• At point C: Did an additional cognitive task, while continuing to walk with eyes still closed, deteriorate gait? The same scoring system was used as in point B.
Not one subject, patient with CFS or nondisabled control, had to be stopped for safety reasons. No one lost direction in such a way that they had to be stopped in order not to collide with the wall. No one opened her eyes to continue walking.
The test was performed once by nondisabled controls and twice-with an interval of <1 min-by patients with CFS. This was done in order to examine the test-retest reliability of the SWECCT test in patients with CFS. The short test-retest time interval was chosen not only for obvious convenience reasons but also to prevent the fluctuating nature of CFS patients' symptoms to interfere with the reliability testing.
Timed Loaded Standing
For TLS, a test originally used by Shipp et al. [6] in osteoporotic patients, we refer to our article in a population of patients with CFS comparing them to nonindustrialized, osteoporotic, and nondisabled populations [7] .
TLS measures the time (in seconds) a person can stand while holding a 1 kg dumbbell in each hand with the arms at 90 of shoulder flexion with elbows extended and wrists in neutral pronation/supination (Figure 2) . The TLS test is a physical performance measure of combined trunk and arm endurance, simulating functional performance of the trunk in daily activities, most of which require the trunk to remain erect and stable while the upper limbs are used [6] . TLS has been shown to generate reliable data, with good intraclass correlation coefficients for same day test-retest and 6 to 10 d test-retest reliability in 127 osteoporotic women with vertebral fractures [6] . Timed loaded standing test. For equipment and specific procedure, see Shipp et al. [6] and Eyskens et al. [7] . This figure was previously published in Eyskens et al. [7] .
Statistical Analysis
To compare the percentage of patients and nondisabled controls who stopped walking, a chi-square test was used. When numbers were small, a Fisher exact test was performed. The actual scoring of the test at each point, ranging from 0 to 3, was compared between both groups with a Mann-Whitney U test. Agreement between test and retest was assessed by weighted kappa coefficients. Interpretation of kappa coefficients is done according to Landis and Koch [44] .
The Spearman correlation coefficient was calculated to examine the association between the data from the TLS with the SWECCT data. To describe the relationship between TLS and SWECCT test results, a linear regression model was used. The square root of TLS was used in order to achieve normality of the residuals.
Logistic regression models were fitted to discriminate between patients with CFS and a nondisabled population on TLS and/or SWECCT results. For these models, sensitivity, specificity, and accuracy are reported. Table 1 shows the demographic data for both populations, patients with CFS and nondisabled controls. Since the nondisabled control group was tested only once, only the results from the first test of patients with CFS were used for comparison. Table 2 shows the main findings of the SWECCT test in patients with CFS versus nondisabled controls. Of the patients with CFS, 55.9 percent stopped walking during test performance compared with only 5.3 percent in the control group (p < 0.001).
RESULTS
Comparing Gait Automaticity Between Patients with Chronic Fatigue Syndrome and Nondisabled Controls
Then, findings are shown for each point. Already at point A ( Table 2) , a difference between both groups can be noted. Of the patients with CFS, eight (23.5%) looked toward the ground and/or at their feet before initiating gate compared with only one (2.6%) control subject (p = 0.01). Demographic data for female patients with chronic fatigue syndrome (CFS) (n = 34) and nondisabled controls (n = 38). Normally distributed parameters represented as mean ± standard deviation; for non-normally distributed data, median (Q1-Q3) is given.
Demographic Nondisabled Controls Patients with CFS
* p < 0.05. Q = quartile.
Table 2.
Gait automaticity in female patients with chronic fatigue syndrome (CFS) (n = 34) and nondisabled controls (n = 38) using "stops walking with eyes closed with secondary cognitive task" test, n (%). At point B, after closing their eyes, 8.8 percent of patients with CFS stopped walking compared with no subjects in the nondisabled control group (p = 0.10). Significantly more patients with CFS deteriorated dramatically or even stopped walking at point B compared with the control group (38.2% vs 2.6%, p = 0.001). Table 3 shows the results of the test-retest in patients with CFS. Of the 19 patients who stopped walking in the first test, 12 also stopped in the second test, and 2 patients who didn't stop in the first test stopped in the second.
Test-Retest Reliability of SWECCT Test in Patients With Chronic Fatigue Syndrome
At point A, eight patients with CFS focused their eyes on the ground before initiating gait. One patient who did not look toward the ground before walking did so during the second test. At the same time, one patient who looked toward the ground during the first test did not do so during the second. At point B, three patients stopped twice. It seemed that six patients walked less unbalanced during the second test, while one patient had more difficulties. At point C, 22 patients had the same level of deterioration in both tests, but 10 patients had fewer deterioration problems in the second test.
The agreement between the first and second test is high at points A and B (kappa = 0.84 and 0.85, respectively) but much lower at point C (kappa = 0.55) and for global stopping/no stopping (kappa = 0.48) ( Table 3) . At point C, a lot of patients improved as a result of performing the test twice. The test-retest reliability for point C and global stopping of the SWECCT test is moderate.
Is Gait Automaticity in Patients with Chronic Fatigue Syndrome Related to Their Trunk and Arm Endurance?
The results of the TLS test in patients with CFS have been presented in a previous article [7] . Figure 3 shows the relation between both data sets. The TLS and SWECCT tests are inversely related (Spearman correlation = 0.59, p = 0.001).
To distinguish patients with CFS from nondisabled controls, both TLS and SWECCT test results were compiled. Figure 3 shows the results based on a logistic regression model with the TLS and SWECCT tests. Sensitivity (percentage of correctly classified patients with CFS), specificity (percentage of correctly classified nondisabled controls), and accuracy (total percentage of correctly classified subjects) have been calculated ( Table 4 ). The same strategy was used based solely on TLS, solely on the SWECCT test, and based on combined TLS and SWECCT test results. When combined with SWECCT test results, the predictive value of TLS becomes even stronger.
DISCUSSION
This is the first study examining the relation between walking and vision in female patients with CFS. In response to the study's three aims, we first can conclude that gait automaticity is impaired in female patients with CFS compared with nondisabled controls. Of patients with CFS, 55.9 percent stopped walking compared with Table 3 . Test-retest reliability of "stops walking with eyes closed with secondary cognitive task" test in female patients with chronic fatigue syndrome by number of patients (n = 34): continuing or cessation of walking. only 5.3 percent of nondisabled controls when completing a cognitive task with eyes closed. Second, the testretest reliability of the SWECCT test used for assessing gait automaticity in patients with CFS is moderate. Third, results obtained with the SWECCT test were inversely related (Spearman correlation = 0.59, p = 0.001) to the TLS test, showing an inverse relation between gait automaticity and trunk arm endurance in female patients with CFS. Combined with the SWECCT test results, the predictive value of TLS becomes even stronger.
Test
Comparing our data with previous findings is impossible because no DT test has been used previously in studies examining patients with CFS. However, the present observations might explain in part why patients with CFS often report difficulties when walking for a prolonged time [3] [4] [5] and are unable to reach the recommended 10,000 steps per day [25] . These limitations may also result from their fatigue [25] .
In addition, the results of Paul et al.'s work, which note that patients with CFS walked slower but also at a higher cost at matched-velocity than nondisabled controls, can be understood based on lost automaticity [25] [26] .
Current rehabilitation guidelines for patients with CFS prescribe graded exercise therapy (GET) and cognitive behavioral therapy. If the present findings are confirmed by others and if future work shows that the observed reduced gait automaticity in patients with CFS is of clinical importance, adding gait automaticity training to current rehabilitation programs for CFS seems warranted [45] [46] [47] .
STUDY LIMITATIONS
A few methodological issues regarding the present study must be mentioned. Regarding the subjects, since only women were studied, external validity of the results is therefore limited to female adult patients with CFS. A few parameters of the included participants were not taken into account, such as menopausal state and levels of education, intelligence, and socioeconomic status.
Another limitation could be that patients with CFS had more or greater vision problems than the control group. Also, tests for assessing the participants' mathematical skills with both eyes open could have been performed to further examine the comparability of the two groups.
Blinding of the assessor was practically impossible because the nondisabled control population consisted of healthy nurses and doctors wearing their hospital uniforms. Hence, future studies should examine whether the observed differences remain when using blinded assessors. Given the use of hospital staff as control subjects, familiarity of the setting differed between groups. This might have affected the study findings in a way that overestimates the differences between the two groups.
Since there was only one observer for examining the reliability of the SWECCT test in patients with CFS, studies examining the test's interobserver reliability, validity, and responsiveness to change are needed. The test could be repeated using up to three observers or using a video camera to score results later using as many observers as needed.
The cross-sectional nature of the study has its limitations. Longitudinal data are required to examine the stability of these findings in a condition such as CFS, which is characterized by high health-status fluctuations over time.
Although this study was a pilot study with only a limited number of participants and without a formal a priori power calculation, significant differences between patients with CFS and nondisabled controls could be demonstrated. However, additional data are needed to confirm these results.
The SWECCT test has been shown to generate reliable data. Comparison with a gold standard could help to demonstrate its true validity. When combined with TLS results, SWECCT test results gain a stronger predictive value to discriminate between patients with CFS and nondisabled controls.
Hence, more research is needed to underpin these findings and their implications for treatment. Comparing both physical outcomes with data of three psychological tests (the RAND 36-Item Health Survey, Symptom Checklist 90, and Checklist Individual Strength) in the same CFS population could help us to understand these functional findings. Results of this study will be published later. 
CONCLUSIONS
Taking the study limitations into account, the present study suggests that gait automaticity is impaired in female patients with CFS compared with nondisabled controls. We found the test-retest reliability of the SWECCT test for assessing gait automaticity in patients with CFS to be moderate. The test-retest reliability is moderate for point C-that part of the test in which subjects had to add a cognitive function when walking with eyes closed-and for global stopping of the SWECCT test.
Further work, including possible adaptations to the test, is required to improve the reliability of all parts of the SWECCT test for patients with CFS. Future studies should examine the test's test-retest reliability, inter-and intrarater validity, and responsiveness to change in a condition characterized by fluctuations.
Finally, the study data indicate that impairments in gait automaticity in patients with CFS are inversely related to combined trunk and arm endurance. When both tests are combined, a stronger predictive value is obtained to discriminate between patients with CFS and nondisabled controls. More research is needed, e.g., addressing the loss of gait automaticity as a treatment plan and/or including a program prior to GET to address this specific problem. Additional Contributions: Suggestions and advice have been given to all of us during the process of developing this article. We thank all for their help but especially wish to mention Hugo Stuer, MD; Bart Leroy, MD; and Luc De Nil, MSc, PT, for the many hours discussing CFS in an inter-and transdisciplinary way. We would also like to thank the staff of the Antwerp University Hospital (Antwerp, Belgium) for administrative, technical, and material support. Institutional Review: The study protocol was approved by the Ethics Committee of the University Hospital Antwerp and written informed consent was obtained from all study participants.
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